123 related articles for article (PubMed ID: 26899324)
21. Human ZNF312b promotes the progression of gastric cancer by transcriptional activation of the K-ras gene.
Song IS; Oh NS; Kim HT; Ha GH; Jeong SY; Kim JM; Kim DI; Yoo HS; Kim CH; Kim NS
Cancer Res; 2009 Apr; 69(7):3131-9. PubMed ID: 19318583
[TBL] [Abstract][Full Text] [Related]
22. Second primary cancers after resection of lung adenocarcinoma with ras gene mutation.
Sugio K; Fukuyama Y; Sakada T; Nishioka K; Yamazaki K; Ushijima C; Tsukamoto S; Ishida T; Sugimachi K
Anticancer Res; 1998; 18(5A):3395-8. PubMed ID: 9858914
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
24. No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers.
Victor T; Du Toit R; Jordaan AM; Bester AJ; van Helden PD
Cancer Res; 1990 Aug; 50(16):4911-4. PubMed ID: 2199031
[TBL] [Abstract][Full Text] [Related]
25. Translating gastric cancer genomics into targeted therapies.
Ang YL; Yong WP; Tan P
Crit Rev Oncol Hematol; 2016 Apr; 100():141-6. PubMed ID: 26947813
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the K-ras and p53 genes in rat lung tumors.
Belinsky SA; Swafford DS; Finch GL; Mitchell CE; Kelly G; Hahn FF; Anderson MW; Nikula KJ
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):901-6. PubMed ID: 9255578
[TBL] [Abstract][Full Text] [Related]
27. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
28. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
29. K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach.
van Rees BP; Musler A; Caspers E; Drillenburg P; Craanen ME; Polkowski W; Chibowski D; Offerhaus GJ
Hepatogastroenterology; 1999; 46(27):2063-8. PubMed ID: 10430398
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of ras oncogene activation in human lung cancer.
Rodenhuis S; Slebos RJ
Cancer Res; 1992 May; 52(9 Suppl):2665s-2669s. PubMed ID: 1562997
[TBL] [Abstract][Full Text] [Related]
31. Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
Keohavong P; DeMichele MA; Melacrinos AC; Landreneau RJ; Weyant RJ; Siegfried JM
Clin Cancer Res; 1996 Feb; 2(2):411-8. PubMed ID: 9816185
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of ras mutations in human lung cancer. Minireview.
Vachtenheim J
Neoplasma; 1997; 44(3):145-9. PubMed ID: 9372854
[TBL] [Abstract][Full Text] [Related]
33. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
[TBL] [Abstract][Full Text] [Related]
34. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
[TBL] [Abstract][Full Text] [Related]
35. [Expression and mutation of p53 and H-ras genes in the carcinogenesis and development of gastric adenocarcinoma induced by MNNG in rats].
Meng Z; Lei D; Wang J
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):117-9. PubMed ID: 11244961
[TBL] [Abstract][Full Text] [Related]
36. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
[TBL] [Abstract][Full Text] [Related]
37. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
38. Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
Choi H; Kratz J; Pham P; Lee S; Ray R; Kwon YW; Mao JH; Kang HC; Jablons D; Kim IJ
Int J Oncol; 2012 Jun; 40(6):1900-6. PubMed ID: 22407457
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers.
Kitagawa Y; Wong F; Lo P; Elliott M; Verburgt LM; Hogg JC; Daya M
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):45-54. PubMed ID: 8679221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
